effect on adult cells, FCS failed to influence 7-chain synthesis in fetal burst forming units-erythroid (BFU-E) colonies. There was a high correlation of y-globin expression in paired cultures done with C-FCS or fetal sheep serum. Dose-response experiments showed that the induction of 7-globin expression is dependent on the concentration of FCS. These results indicate that FCS contains an activity that induces y-globin expression in adult erythroid progenitor cell cultures. 0 1990 by The American Society of Hematology.
activities that can induce H b F production in cultures of adult erythroid progenitors.
MATERIALS AND METHODS
Peripheral blood was obtained from hematologically normal adult volunteers and people with sickle cell anemia, &thalassemia, hereditary persistence of fetal hemoglobin (HPFH), or other conditions (Diamond-Blackfan, juvenile chronic myeloid leukemia (JCML), hemoglobin H (HbH), a-thalassemia, etc). Patients with @-thalassemia were homozygotes of varying degrees of severity (polytransfused cases of Cooley's anemia or thalassemia intermedia). The blood was collected with phlebotomy in sterile preservative-free heparin. Mononuclear cells were obtained by centrifugation of the blood over Hypaque-Ficoll (Lymphoprep, Nyegaard, Norway), washed in phosphate-buffered saline (PBS), and incubated in a-media containing 5% FCS in plastic Petri dishes for 1 hour at 37OC, in order to remove adherent cells (monocytes and macrophages). After low speed centrifugation, the cells were resuspended in Iscove's modified Dulbecco's medium (IMDM) with 5% FCS and used for cultures (see below).
Fetal liver and yolk sac samples were obtained from dead abortuses after maternal consent. The tissues were rinsed well, finely minced and the cells were mechanically dispersed by vigorous pipeting, counted, and used for culture. Bone marrow was aspirated into heparinized syringes from the iliac crest of the donors. Bone marrows from normal non-hemoglobinopathic persons were mainly obtained from donors of the bone marrow transplantation program. Bone marrow from sickle cell patients was obtained during steady state and also during treatment with cytosine arabinoside (Ara-C) or hydroxyurea or recombinant erythropoietin. Separation of mononuclear cells was done as described above. In fetal liver, yolk sac, or bone marrow experiments, total mononuclear cells (without removal of adherent cells) was used for culture.
After cell counting, the cell suspensions were adjusted to suitable plating concentrations. Cells were inoculated (2 to 5 x io5 cells/ mL) in either plasma clot or methylcellulose. When plasma clotsz2 were used, the following components were employed: beef embryo extract (BEE; Grand Island Biological Co, Grand Island, NY) 10%; bovine serum albumin (BSA; Intergen, Purchase, NY) 10%; 2mercaptoethanol (Sigma Chemical Co, St Louis, MO) mol/L; FCS (Rehatuin; Intergen) 30%; FSS or plasma (collected from fetuses between 80 and 120 days of gestation) 30%; human AB serum 10%; recombinant human erythropoietin (Genetics Institute, Cambridge, MA) 0.2 U/mL; and bovine citrated plasma (BCP; Irvine Scientific, Santa Anna, CA) 10%. In the methylcellulose c u l t~r e s , '~,~~ the following components were used: methylcellulose (Fisher Scientific, Fair Lawn, NJ) 0.9%; human AB plasma 10%; erythropoietin 2.0 U/mL; FCS, BSA, and 2-mercaptoethanol, all in concentrations as above.
Five different lots of FCS from two vendors were used during the Bedford, MA). In the dialysis studies, both FCS or charcoal-treated FCS (C-FCS), were dialyzed against PBS at 4OC for 12 to 16 hours, using Spectra/Por tubing membranes (Spectrum Medical Industries Inc, Los Angeles, CA) in various molecular weight cut off pore sizes.
In several experiments, increasing concentrations of FCS were added on top of 30% C-FCS or FSS used in the culture media. The final volume of media per culture plate was kept at 1.15 mL by adjusting the concentrations of the stock solutions of BSA and methylcellulose and by suspending the cell pellet in serum (C-FCS or FSS) instead of IMDM.
Cultures were incubated in a highly humidified 37OC incubator and continuously flushed with 5% CO,. Erythroid colony forming units (CFU-E, 8 to 64 mature erythroblasts) were evaluated in benzidine-hematoxylin stained plasma clots at day 3 to 5 in culture. BFU-E colonies (usually greater than 100 and up to several thousand cells per colony) were evaluated in either plasma clot or methylcellulose cultures at 10 to 16 days in culture.
The methodologies used for globin chain biosynthesis of culture-derived cells have been described CFU-E-derived colonies were labeled at day 5 with [3H]-leucine (Amersham, Arlington Heights, IL) for 12 to 16 hours. At the end of the incubation period, the plasma clots were washed with normal saline and the cell pellets were either analyzed immediately or stored in liquid nitrogen. Globin biosynthesis in BFU-E-derived colonies was carried out in bursts plucked from methylcellulose cultures, usually on culture days 14 to 16. Individually lifted bursts were pooled and incubated with ['HI-leucine (300 to 400 pCi/mL), and after washing, the cells were either analyzed for globin chains or stored in liquid nitrogen.
To determine the levels of globin chain synthesis, the plasma clot-derived colonies were lysed with 10% Nonidet P-40 and 0.01% KCN for 1 hour on ice and centrifuged (14,OOOg for 2 minutes). After addition of nonradioactive HbA and HbF carriers, cell lysates (2 to 4 pL) were mixed with 25 pL of denaturing buffer (8 mol/L urea, 10% @-mercaptoethanol, and 2% NP-40), and isoelectric focusing was carried out as previously described." After focusing, the gels were fixed in 20% trichloroacetic acid (TCA) in 30% ethanol for 5 to 6 hours, incubated in EN-3HANCE (New England Nuclear, Boston, MA) for 1 to 2 hours, dried on a slab gel dryer, and exposed on preflashed Kodak X-OMAT-VR film. Relative densities of the globin chain bands (a, @, Gy, and Ay) were determined on a Gelman automatic computing densitometer.
Total cellular RNA was isolated using the method of Karlinsey et a1.28 RNAse protection assay was performed as described by Zinn et aIz9; 1 pg total RNA was used for each hybridization reaction with y-and @-globin specific RNA probes.
For the blot hybridization method, the cells were prepared as follows: dilutions of 50.000, 10,000, and 2,000 cells were washed twice in PBS, and then the cell pellet was resuspended in cold TE buffer (10 mmol/L Tris, 0.1 mmol/L EDTA) and 20 units of RNAse inhibitor was added (RNasin; Promega, Madison, WI). The cells were then lysed with a 5% NP-40 solution, and after centrifugation, the cytoplasm was transferred to tubes containing 20x SSC (0.15 mol/L NaCI, 0.015 mol/L trisodium citrate) and 37% formaldehyde. After denaturing at 65OC for 15 minutes, the sample was immediately processed for "spot blotting," or stored at -7OOC for later analysis.
The "spot blotting" technique of Kafatos et aI3' was employed using the Schleicher & Schuell (Keene, NH) Minifold I1 apparatus, as previously described." The samples were diluted to a final volume Globin synthesis.
RNA studies.
of 300 pL with 15x SSC and loaded on prewet (15x SSC)
Schleicher & Schuell nitrocellulose paper under vaccum. After drying, the nitrocellulose was baked in a vacuum oven at 8OoC for 2 hours. After a 3-hour prehybridization in a 65OC water bath, the blots were hybridized with 50 ng of in vitro transcribed radioactive (a-"P-uridine triphosphate [UTP]) RNA probes. For detection of @-globin mRNA, the 0.7 kb Pst I/EcoRI fragment containing the 3' end of the human genomic @-globin gene was subcloned in antisense orientation in a T7-plasmid vector. For the detection of y-globin mRNA, the 0.6 kb EcoRIIHindIII fragment of the 3' end of the human Gy-globin gene was subcloned in an Sp6-plasmid vector. Hybridization was allowed to take place between the homologous RNA sequences for at least 16 hours, followed by extensive washing under stringent conditions (2x SSC with 0.1% sodium dodecyl sulfate [SDS] at 65OC six times, followed by 0 . 1~ SSC with 0.1% SDS at 65OC two times). After exposing the blot on a Kodak X-OMAT-AR film at -7OoC, the relative amounts of y-and @-globin mRNAs were calculated by both scanning in a densitometer and by directly measuring the radioactivity (counts/min) of every slot in a liquid scintillation @-counter.
RESULTS
Induction of y-chain synthesis in peripheral blood BFU-E cultures. Experiments were designed in a pair-wise fashion so that within each pair all conditions were identical, except that in one set of cultures, untreated FCS was used while in the other set of cultures, C-FCS was used. When charcoaltreated FCS was used in culture, cloning efficiency of normal peripheral blood BFU-E was 1.57-fold higher (n = 39) and of normal bone marrow, BFU-E was 1.84-fold higher (n = 13) compared with FCS controls. Results of globin biosynthesis are shown in Fig 1. In normal BFU-E cultures (n = 34), consistently higher y/y + 0 ratios were found when cells were grown in FCS as compared with C-FCS. On the average, the y/y + ( 3 ratios were 3.6-fold higher in the FCS cultures than in C-FCS cultures (range, 1.5-fold to 6.5-fold). Similar results were obtained in cultures of cells from patients with sickle cell disease; in 20 experiments, there was a 3.2-fold mean increase in y/y + @ ratios (range, 1.3-fold to 5.7-fold). A significant induction of y-globin expression in FCS cultures was also observed in cultures of homozygous @-thalassemia BFU-E; in 18 experiments, there was a 2.2-fold mean increase in y/y + @ ratios. Five of six @-thalassemia heterozygotes displayed an increase in y/y + @ ratios in FCS cultures (Fig 1) . Six cases of HPFH (deletion or non-deletion mutants) showed an average y/y + B increase of 2.9-fold in the presence of FCS. The "other conditions" in Fig 1 include cases of Diamond Blackfan syndrome and HbH disease. The only condition that consistently failed to respond to FCS by an increment of y/y + @ ratio was JCML (data not shown).
Steady state of y/y + @ globin mRNA ratios were determined in six experiments of normal peripheral blood BFU-E cultures. In one experiment, a n RNAse protection assay was used, while in five experiments we used a blot hybridization assay. A twofold to ninefold increase in y/y + @ mRNA ratios was observed when FCS was used instead of C-FCS in the culture medium ( Table 1) Table   1) . Effect of FCS on bone marrow erythroid progenitors. The effect of FCS on y-globin production was also examined in bone marrow-derived colonies. The y/y + P ratios in FCS cultures were 2.3-fold higher than in C-FCS cultures in normal bone marrow BFU-E (range, 1.5-fold to 3.1-fold) and 1.8-fold higher in CFU-E (range, 1.1-fold to 2.6-fold) (Fig 2) . The increase in y/y + ratio was fourfold in sickle cell anemia BFU-E (range, 1.9-fold to 8.6-fold) and 2.4-fold in the CFU-E (range, 1 S-fold to 2.9-fold). A similar increase of y/y + ratios in FCS cultures was also noted in cultures of bone marrow progenitors of homozygous P-thalassemics (one experiment), heterozygous P-thalassemics (two experiments), and in six experiments using cells from other disorders.
To examine the effect of FCS on y/y + P ratios of fetal erythroid progenitors, paired cultures of fetal liver or yolk sac origin BFU-E were done in FCS or C-FCS. As shown in Table 2 , in seven experiments using fetal liver cells and two experiments using yolk sac cells, there was essentially no difference in y/y + P ratios between FCS and C-FCS cultures.
Comparison of y/y + / 3 ratios in C-FCS-or FSS-grown erythroid cultures. Paired cultures were done to compare y/y + P ratios in C-FCS or FSS plasma-grown BFU-E
Effect of FCS on fetal origin BFU-E.
Conditions stimulates 7-globin expression.
colonies. Figure 3 presents results using adult peripheral blood BFU-E (Fig 3A) or adult bone marrow BFU-E ( Fig  3B) . A significant correlation was obtained in both; correlation coefficients were r = .75 in 40 peripheral blood BFU-E comparisons and r = .85 in 38 bone marrow BFU-E comparisons.
The increase in y/y + p ratios by FCS is concentrationdependent. The following experiments were done to test whether the effect of FCS on the y/y + p ratio is quantitative. First, adult peripheral blood BFU-E cultures were performed in medium containing increasing concentrations of FCS (5%, lo%, 15%, 20%, 25%, 30%, and 40%; all cultures were done in the presence of 10% adult human AB plasma). Colonies (usually at culture days 14 to 16) were plucked from the cultures, pooled, and used for globin biosynthesis. Control cultures were done using increasing concentrations (from 5% to 40%) of C-FCS. While there was no change in the y/y + ratios in the C-FCS cultures, a clear increase was observed in response to the increase of serum concentration in the FCS cultures (Fig 4) .
Since there are differences in growth between cultures done with low or with high serum concentrations, we repeated the experiments using conditions that minimized differences in progenitor cell growth. Increasing concentrations of FCS (from 0% to 30%) were added to media that already contained 30% C-FCS or 30% FSS. Peripheral blood BFU-E from patients with homozygous j3-thalassemia ( Fig  5A) or heterozygous HPFH ( Fig 5B) were used for these studies. In both types of cultures, there was an FCS concentration-related increase in y/y + j 3 ratios. As Fig 5B shows, plateau levels of y/y + j3 synthesis were reached a t 15% to 20% FCS.
In the third series of experiments, increasing concentrations of FCS (from 0% to 30%) were added to cultures grown in the presence of a range of concentrations of FSS (from 0% to 25%). A clear relationship between FCS concentration and levels of y/y + j3 ratio was again observed (Fig 6) .
To test whether late addition of FCS in culture affects y-globin synthesis, peripheral blood mononuclear cells were grown in C-FCS media, and on day 8, colonies were collected and divided in two parts. One was transfered into another C-FCS-containing plate, while the other part was transfered to an FCS-containing plate. In the C-FCS to C-FCS transfer, the y/y + j3 ratio was 0.04 on day 13 and 0.04 on day 15. In the C-FCS to FCS transfer, the y/y + j3 ratio was 0.11 on day 13 and 0.13 on day 15. These data suggest that FCS can induce y-globin expression in late erythroid progenitors. Similar conclusions can be drawn Other studies. (Table 3) suggests that the molecular size of this factor is greater than 25 Kd. Finally, gel filtration chromatography of FCS resulted in elution of the HbF stimulating activity with the large molecular weight fractions. In these experiments, the tubes of chromatographic eluent were pooled (in four pools), the pools were concentrated by ultrafiltration to the initially applied to the column or FCS volume, and 0.2 mL aliquots were added in peripheral blood BFU-E cultures (done using cells from the same person), and effects on globin biosynthesis were assessed. In one G-200 Sephadex experiment, the highest induce y-globin expression even when it acts at the level of early erythroblast (or on late progenitors maturing during the 16 hour-incubation period). Preliminary results suggest that the FCS activity that increases the y/y + /3 ratio has a relatively high molecular weight. First, treatment of FCS with BSA-coated or dextrancoated charcoal did not result in the loss of the HbF stimulating activity ( Table 3) . Since charcoal particles presaturated with large molecules such as BSA or dextran can only adsorb small molecules,32 this result suggests that the factor in FCS is a large molecule. Second, dialyzed FCS 
DISCUSSION
Our data show that serum from calf fetuses contains an activity (or activities) that increases the relative synthesis of HbF in erythroid cultures. This activity induces y-globin synthesis in peripheral blood BFU-E and in bone marrow BFU-E and CFU-E cultures of normal persons and of individuals with a variety of hematologic conditions. The effect of the activity on H b F is mediated through a relative increase in steady-state y-globin mRNA. The effect of FCS on y-globin expression is quantitative: in several experiments, there was an increment in y/y + @ ratios when the concentration of FCS was raised in culture. While there was a consistent induction of y-globin synthesis in the adult BFU-E cultured in FCS, there was essentially no effect in BFU-E cultures of fetal origin. These results confirm previous observations2' that FCS contains a charcoal removable factor(s) that induces HbF in adult BFU-E cultures.
The possibility that the sera used in culture contain activities that can affect fetal globin expression was first realized when it was observed that, in contrast to the cultures done with FCS, cultures done with FSS had low y-globin p r o d u~t i o n . ' '~~~ While FSS decreased y/y + @ ratios in adult BFU-E cultures, there was no such effect in cultures of fetal BFU-E.'9.20.33 Most interestingly, FSS inhibited y-globin biosynthesis in cultures of H P F H or &@-thalassemia BFU-E.33.34 These results suggest that FSS contains a "hemoglobin switching activity," which inhibits y-globin expression and enhances P-globin expression. By culturing cells in FSS and subsequently lifting the colonies and subculturing them in FCS (or the opposite), we showed that this "switching activity" was acting on cells of early as well as late erythropoiesis.20 By using single cell clones, splitting them in two parts a t an early stage of their development (less than 50 cells); and subculturing each part in either FCS or FSS, we showed that sibling clones can have either high or low y/y + @ ratios, depending on the environment in which the clones grow (ie, whether they are grown in FCS or FSS20.34). Does FSS contain an inducer for y to @ switching, as we have postulated, or does it simply lack the y-globin inducer that is present in FCS?
Results of comparisons of globin biosynthesis in paired FSS or C-FCS cultures support the possibility that FSS cultures display low y/y + @ synthesis because they lack the inducer present in FCS (Fig 3) . Also, like FSS, C-FCS does not affect y/y + @ ratios on fetal BFU-E cultures. The significant inhibition of y-globin expression in FSS-grown HPFH and @-thalassemia BFU-E culture^^^'^^ supports the existence, in FSS, of an activity that inhibits y expression and increases @ expression. It is possible that fetal sera contain two types of activities: a y-globin inducer like the one removed by charcoal treatment of FCS and a y-globin inhibitor that is revealed by the effect of FSS on HPFH mutants.
Our studies provide insights on whether FCS induces y-globin expression by acting at the transcriptional or at the post-transcriptional levels. We have compared globin gene expression in FSS and FCS cultures by analyzing y-and @-globin gene methylation, y-and @-globin gene DNAse 1 hypersensitivity, and y-and @-globin gene tran~cription.~' These studies showed that the differences in y-globin biosynthesis between FCS or FSS cultures reflect differences at the level of methylation and the degree of DNAse 1 sensitivity of the y genes.35 Run off transcription assays showed that differences in y/y + @ biosynthetic ratios reflect differences at the level of y-gene tran~cription.~~ In this article, we show that the differences in y/y + @ globin biosynthetic ratios between FCS and C-FCS cultures reflect differences a t the level of steady-state globin mRNA. We conclude that the factor@) contained in FCS induce y-globin expression through an effect a t the transcriptional rather than the posttranscriptional level.
How does FCS exert its effect at the cellular level? Various mechanisms can be proposed. First, the factor in FCS may produce in culture an environment of "stress erythropoiesis" leading to "premature commitment" of progenitors, a condition thought to result in activation of fetal globin expression." use only.
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